In a groundbreaking move, Scotland has launched the UK's first newborn screening program for Spinal Muscular Atrophy (SMA), a rare genetic disorder that can severely limit life expectancy to just two years without treatment. The progressive muscle-wasting condition affects approximately one in 6,000 births, and early detection through this screening could prove life-changing for affected families.

Health officials have hailed the initiative as a significant step forward in pediatric healthcare. By identifying SMA within days of birth, medical interventions can begin early, dramatically improving outcomes for infants who would otherwise face severe physical challenges. The Scottish government plans to evaluate the program's effectiveness with hopes of expanding screening capabilities for other rare genetic conditions in the future.